
Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetyl carnitine, or combined L-carnitine and L-acetyl carnitine in men with idiopathic asthenozoospermia.
Fertility & Sterility 2005 Sep;84(3):662-71. Andrology unit, Department of Internal Medicine, Polytechnic University of Marche, Italy.
We evaluated the effectiveness of L-carnitine or acetyl carnitine or combined carnitine and acetyl carnitine treatment in improving semen kinetic parameters. Sixty infertile men, ages 20 to 40 years, with the following baseline sperm selection criteria: concentration > 20 x 10(6)/mL, sperm forward motility <> 30%. Patients underwent a double-blind therapy of carnitine 3 grams a day, acetyl carntine 3 grams a day, a combination of carnitine 2 g/d and acetyl carnitine 1 g/d, or placebo for a period of six months. Sperm cell motility increased in patients to whom acetyl carnitine was administered both alone or in combination with carnitine; combined carnitine + acetyl l carnitine therapy led to a significant improvement of straight progressive velocity. The administration of carnitine and acetyl carnitine is effective in increasing sperm kinetic features in patients affected by idiopathic asthenozoospemia and improves the total antioxidant status of the seminal fluid.
No comments:
Post a Comment